CIOMS Working Group VIII on Application of Signal Detection in Pharmacovigilance (CIOMS VIII)
The conclusions of this Working Group have been finalized and published. In 2006, based on requests from some drug regulatory authorities and a number of pharmaceutical companies, CIOMS set up a working group of senior scientists (from drug regulatory authorities, the pharmaceutical industry, and academia) in order to develop consensus Points to Consider in the development and application of quantitative methods for signal detection using pharmacovigilance databases. The publication contains key definitions of pharmacovigilance, taxonomy of drug safety signals, description of approaches to signal detection including both traditional and statistical data mining methods and interpretation of results. Data elements, mechanisms and different systems of spontaneously reported data including discussions on limitations and challenges of spontaneous data are presented. Signal detection strategies and program, stakeholder perspectives and signal management are also addressed. Finally future directions in signal detection, evaluation and communication are elaborated.
The following meetings have taken place:
- September 2006, EMEA, London, UK
- November 2006, WHO/CIOMS, Geneva, Switzerland
- April 2007, Food and Drug Administration, Rockville, Maryland, USA
- October 2007, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany
- March 2008, French Health Products Safety Agency (Afssaps), Paris, France
- October 2008, Medicines and Health Products Regulatory Agency (MHRA), London, UK.